A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

While hydroxychloroquine (HCQ) helps reduce disease flares in lupus, its effect on renal function in patients with lupus ...

This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year’s recipients are Nayimisha Balmuri, MD, Assistant ...

Lupus nephritis articles from across Nature Portfolio Lupus nephritis is an inflammatory kidney disease (glomerulonephritis) that develops in patients with systemic lupus erythematosus (SLE).

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.

Chronic exposure to the systemic inflammation caused by the autoimmune disease may explain the associations found, say the researchers.

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...